Prof. Dr. Christian Pilarsky



Organisationseinheit


Professur für Chirurgische Forschung
Chirurgische Klinik


Publikationen (Download BibTeX)

Go to first page Go to previous page 1 von 2 Go to next page Go to last page

Patzak, M.S., Kari, V., Patil, S., Hamdan, F.H., Goetze, R.G., Brunner, M.,... Neesse, A. (2019). Cytosolic 5 '-nucleotidase 1A is overexpressed in pancreatic cancer and mediates gemcitabine resistance by reducing intracellular gemcitabine metabolites. EBioMedicine, 40, 394-405. https://dx.doi.org/10.1016/j.ebiom.2019.01.037
Casadonte, R., Kriegsmann, M., Perren, A., Baretton, G., Deininger, S.-O., Kriegsmann, K.,... Kriegsmann, J. (2019). Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging. Proteomics Clinical Applications, 13(1). https://dx.doi.org/10.1002/prca.201800046
Kalb, M., Langheinrich, M.C., Merkel, S., Krautz, C., Brunner, M., Bénard, A.,... Weber, G. (2019). Influence of body mass index on long-term outcome in patients with rectal cancer-a single centre experience. Cancers, 11(5). https://dx.doi.org/10.3390/cancers11050609
Liu, B., & Pilarsky, C. (2018). Analysis of DNA Hypermethylation in Pancreatic Cancer Using Methylation-Specific PCR and Bisulfite Sequencing. Methods in molecular biology (Clifton, N.J.), 1856, 269-282. https://dx.doi.org/10.1007/978-1-4939-8751-1_16
Britzen-Laurent, N., Straube, J., Waldner, M., Becker, C., Croner, R., Pilarsky, C.,... Stürzl, M. (2018). Loss of IFN-gamma pathway gene expression in tumor cells as mechanism of immune escape of colorectal carcinoma. In CANCER RESEARCH. Chicago, IL, US: PHILADELPHIA: AMER ASSOC CANCER RESEARCH.
Christodoulou, E.G., Yang, H., Lademann, F., Pilarsky, C., Beyer, A., & Schroeder, M. (2017). Detection of COPB2 as a KRAS synthetic lethal partner through integration of functional genomics screens. Oncotarget, 8(21), 34283-34297. https://dx.doi.org/10.18632/oncotarget.16079
Humphris, J.L., Patch, A.-M., Nones, K., Bailey, P.J., Johns, A.L., Mckay, S.,... Pilarsky, C. (2017). Hypermutation In Pancreatic Cancer. Gastroenterology, 152(1), 68-74.e2. https://dx.doi.org/10.1053/j.gastro.2016.09.060
Mayerle, J., Kalthoff, H., Reszka, R., Kamlage, B., Peter, E., Schniewind, B.,... Lerch, M.M. (2017). Metabolic biomarker signature to differentiate pancreatic ductal adenocarcinoma from chronic pancreatitis. Gut. https://dx.doi.org/10.1136/gutjnl-2016-312432
Krebs, A.M., Mitschke, J., Losada, M.L., Schmalhofer, O., Boerries, M., Busch, H.,... Pilarsky, C. (2017). The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer. Nature Cell Biology, 19(5), 518-529. https://dx.doi.org/10.1038/ncb3513
Jahny, E., Yang, H., Liu, B., Jahnke, B., Lademann, F., Knoesel, T.,... Pilarsky, C. (2017). The G Protein-Coupled Receptor RAI3 Is an Independent Prognostic Factor for Pancreatic Cancer Survival and Regulates Proliferation via STAT3 Phosphorylation. PLoS ONE, 12(1), e0170390. https://dx.doi.org/10.1371/journal.pone.0170390

Zuletzt aktualisiert 2017-13-07 um 05:42